abstract |
An object of the present invention is to find a novel component that has a blood neutral fat reducing action and is safe. The composition for reducing blood neutral fat according to the present invention is a xyloglucurono having a main chain composed of α-1,3-mannose and having D-xylose and D-glucuronic acid as side chains. The composition ratio of the α-1,3-mannose and the D-glucuronic acid in the xyloglucuronomannan [α-1,3-mannose: D-glucuronic acid] is 9: 1 to 9: It is 3.5 (moler). The xyloglucuronomannan is preferably extracted from a hetero-basidiomycete species classified as a genus Tremella. The present invention can be used for pharmaceuticals, foods and drinks, cosmetics, and the like. [Selection figure] None |